Anumana
Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. Its platform aims to enhance cardiac care by assisting healthcare professionals in identifying potential heart issues, improving patient outcomes throughout the continuum of cardiovascular care.
Top Sectors
Top Regions
Top Stages
1 past transactions
NeuTrace
Acquisition in 2022
NeuTrace is a medical device company based in Longwood, Florida, that focuses on the development of advanced diagnostics and solutions for heart disease. Founded in 2020, the company leverages artificial intelligence and machine learning to enhance research, diagnosis, and treatment for patients with abnormal heart rhythms. NeuTrace's proprietary platform integrates innovative medical devices with clinical and technical expertise, providing healthcare professionals with effective tools to address heart disease and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.